ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF
CERTAIN OFFICERS.
On December 15, 2021, the Compensation Committee (the "Committee") of the Board
of Directors of DexCom, Inc. (the "Company") approved the following grants of
restricted stock units (the "RSUs") to certain of our named executive officers
under the Company's Amended and Restated 2015 Equity Incentive Plan (the "Plan")
to incentivize employee retention. The grant date of the RSUs shall be December
15, 2021 (the "Grant Date").
Officer Title RSU Grant*
Jacob Leach EVP, Chief Technology Officer 2,925
Jereme Sylvain EVP, Chief Financial Officer 2,925
*The RSUs shall begin vesting on the Grant Date with 50% of the total number of
RSUs vesting on December 15, 2023 and 12.5% of the total number of RSUs vesting
on each of March 8, 2024, June 8, 2024, September 8, 2024 and December 15, 2024,
subject to the grantee's continued Service (as defined in the Plan) and further
subject to any applicable vesting acceleration provisions as are currently
applicable to each grantee.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
DEXCOM, INC. 
